Evidence map›Paper›PMID 36612037›Full record

ReviewCancers2022

Deep Learning for Skin Melanocytic Tumors in Whole-Slide Images: A Systematic Review.

Andrés Mosquera-Zamudio, Laëtitia Launet, Zahra Tabatabaei, Rafael Parra-Medina, Adrián Colomer, Javier Oliver Moll, Carlos Monteagudo, Emiel Janssen, Valery Naranjo

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Deep Learning Image Processing Models in Dermatopathology.Diagnostics (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrés Mosquera-ZamudioSkin Cancer Research Group, INCLIVA, 46010 Valencia, Spain.ORCID 0000-0002-6158-9619
Laëtitia LaunetInstituto Universitario de Investigación en Tecnología Centrada en el Ser Humano, HUMAN-Tech, Universitat Politècnica de València, 46022 Valencia, Spain.
Zahra TabatabaeiInstituto Universitario de Investigación en Tecnología Centrada en el Ser Humano, HUMAN-Tech, Universitat Politècnica de València, 46022 Valencia, Spain.
Rafael Parra-MedinaDepartment of Pathology, Fundación Universitaria de Ciencias de la Salud, Hospital San José, 111411 Bogotá, Colombia.ORCID 0000-0002-8428-5837
Adrián ColomerInstituto Universitario de Investigación en Tecnología Centrada en el Ser Humano, HUMAN-Tech, Universitat Politècnica de València, 46022 Valencia, Spain.ORCID 0000-0002-7616-6029
Javier Oliver MollDepartmentof Artificial Intelligence, Tyris Tech S.L., 46021 Valencia, Spain.
Carlos MonteagudoSkin Cancer Research Group, INCLIVA, 46010 Valencia, Spain.ORCID 0000-0002-9381-9976
Emiel JanssenDepartment of Pathology, Stavanger University Hospital, 4068 Stavanger, Norway.ORCID 0000-0002-7760-5396
Valery NaranjoInstituto Universitario de Investigación en Tecnología Centrada en el Ser Humano, HUMAN-Tech, Universitat Politècnica de València, 46022 Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of Artificial Intelligence (AI) has shown promising performance as a support tool in clinical pathology workflows. In addition to the well-known interobserver variability between dermatopathologists, melanomas present a significant challenge in their histological interpretation. This study aims to analyze all previously published studies on whole-slide images of melanocytic tumors that rely on deep learning techniques for automatic image analysis. Embase, Pubmed, Web of Science, and Virtual Health Library were used to search for relevant studies for the systematic review, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. Articles from 2015 to July 2022 were included, with an emphasis placed on the used artificial intelligence methods. Twenty-eight studies that fulfilled the inclusion criteria were grouped into four groups based on their clinical objectives, including pathologists versus deep learning models (

Indexed as

cancerclassificationcomputational pathologycomputer-aided diagnosisdeep learningdermatopathologymelanocytic tumorsmelanomasegmentationskin

Identifiers

PMID36612037
PMCPMC9817526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.